Dean Capital Investments Management LLC purchased a new stake in shares of Liquidia Technologies Inc (NASDAQ:LQDA) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 54,054 shares of the company’s stock, valued at approximately $1,483,000. Liquidia Technologies accounts for 1.0% of Dean Capital Investments Management LLC’s holdings, making the stock its 2nd largest position. Dean Capital Investments Management LLC owned about 0.35% of Liquidia Technologies at the end of the most recent reporting period.
Separately, BlackRock Inc. purchased a new stake in Liquidia Technologies during the third quarter valued at about $5,924,000. 20.29% of the stock is owned by hedge funds and other institutional investors.
LQDA has been the subject of several analyst reports. Cowen initiated coverage on shares of Liquidia Technologies in a research report on Monday, August 20th. They set an “outperform” rating and a $40.00 price target for the company. Wedbush upped their price target on shares of Liquidia Technologies from $26.00 to $28.00 and gave the company a “buy” rating in a research report on Thursday, November 1st. Zacks Investment Research lowered shares of Liquidia Technologies from a “hold” rating to a “sell” rating in a research report on Wednesday, November 7th. Jefferies Financial Group assumed coverage on shares of Liquidia Technologies in a research report on Monday, August 20th. They set a “buy” rating and a $22.00 price target for the company. Finally, Needham & Company LLC set a $32.00 price objective on shares of Liquidia Technologies and gave the company a “buy” rating in a research note on Wednesday, October 31st. One analyst has rated the stock with a sell rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $31.75.
Liquidia Technologies (NASDAQ:LQDA) last issued its quarterly earnings data on Wednesday, October 31st. The company reported ($0.83) EPS for the quarter, missing the consensus estimate of ($0.57) by ($0.26). The firm had revenue of $0.17 million for the quarter, compared to analysts’ expectations of $1.03 million. As a group, analysts forecast that Liquidia Technologies Inc will post -5.67 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Dean Capital Investments Management LLC Takes $1.48 Million Position in Liquidia Technologies Inc (LQDA)” was originally posted by WKRB News and is the property of of WKRB News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.wkrb13.com/2018/11/23/dean-capital-investments-management-llc-takes-1-48-million-position-in-liquidia-technologies-inc-lqda.html.
Liquidia Technologies Company Profile
Liquidia Technologies, Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies.
Featured Article: Investing in Growth Stocks
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.